• InterView
• “Why it took 20 years for new flu drug Xofluza to be out”
• by Eo, Yun-Ho Jan 16, 2020 03:07pm

• InterView
• “Key to healthcare innovation is pharmaceutical industry"
• by Kim, Jung-Ju Jan 2, 2020 06:08am

• InterView
• Restriction on high dose of Xeljanz
• by Nho, Byung Chul Dec 26, 2019 10:15am

• InterView
• The key to drug development is not just safety and efficacy
• by Jung, Hye-Jin Dec 5, 2019 06:12am

• InterView
• “Independent Galderma aims for both innovation and jobs”
• by Eo, Yun-Ho Dec 4, 2019 06:43am

• InterView
• “Number one in Asia is what we are shooting for”
• by Kim, Jin-Gu Nov 26, 2019 07:15am

• InterView
• I know CRA grievances better than anyone else
• by Lee, Tak-Sun Nov 14, 2019 09:59am

• InterView
• "Use of RWD and AI in new drug development will increase”
• by Park, sangjun Nov 8, 2019 08:55am

• InterView
• 50-year-old Pfizer Korea “For both patients and innovation"
• by Eo, Yun-Ho Nov 6, 2019 08:59am

• InterView
• MFDS nizatidine investigation on NDMA still ongoing
• by Byun Kyung A Nov 1, 2019 04:45pm